(Q34546460)

2 August 2017

1 reference

title

Control or persistence of hepatitis B virus: the critical role of initial host-virus interactions (English)

1 reference

2 August 2017

0 references

1 reference

Antonio Bertoletti

2

0 references

author name string

George Jm Webster

series ordinal

1

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Immunology & Cell Biology

2 August 2017

published in

1 reference

2 August 2017

volume

80

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

101-105

1 reference

Hepatitis B virus biology

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

How can the cellular immune response control hepatitis B virus replication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Immune responses to duck hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Initial and innate responses to viral infections--pattern setting in immunity or disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Cytokine-induced viral purging--role in viral pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Activation and function of natural killer cell responses during viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis f

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Immunosuppression with cyclosporine during the incubation period of experimental woodchuck hepatitis virus infection increases the frequency of chronic infection in adult woodchucks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Heterozygote advantage for HLA class-II type in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Host genetic factors influencing the outcome of hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Functional analysis of HBV genomes from patients with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01060.X

10.1046/J.1440-1711.2002.01060.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference